SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-000534
Filing Date
2023-01-25
Accepted
2023-01-25 16:38:11
Documents
5
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230307xdef14a.htm DEF 14A 948153
2 GRAPHIC tmb-20230307xdef14a001.jpg GRAPHIC 672
3 GRAPHIC tmb-20230307xdef14a002.jpg GRAPHIC 672
4 GRAPHIC tmb-20230307xdef14a003.jpg GRAPHIC 141539
5 GRAPHIC tmb-20230307xdef14a004.jpg GRAPHIC 190103
  Complete submission text file 0001558370-23-000534.txt   1408473
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39619 | Film No.: 23552883
SIC: 2836 Biological Products, (No Diagnostic Substances)